about
Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications.Tissue distribution of blood group membrane proteins beyond red cells: evidence from cDNA libraries.Labeling of mesenchymal stromal cells with iron oxide-poly(L-lactide) nanoparticles for magnetic resonance imaging: uptake, persistence, effects on cellular function and magnetic resonance imaging propertiesReticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2.Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate.Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside.Transportation conditions for prompt use of ex vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration.Phenotypic Characterization of Mesenchymal Stem Cells from Various Tissues.Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II.Antimony-trioxide- and arsenic-trioxide-induced apoptosis in myelogenic and lymphatic cell lines, recruitment of caspases, and loss of mitochondrial membrane potential are enhanced by modulators of the cellular glutathione redox system.Changes of Bone Turnover Markers in Long Bone Nonunions Treated with a Regenerative Approach.mRNA-mediated gene delivery into human progenitor cells promotes highly efficient protein expression.Nilotinib hampers the proliferation and function of CD8+ T lymphocytes through inhibition of T cell receptor signallingPlatelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of activArsenic trioxide-induced apoptosis is independent of CD95 in lymphatic cell lines.GMP-adapted overexpression of CXCR4 in human mesenchymal stem cells for cardiac repair.Effect of high-dose irradiation on human bone-marrow-derived mesenchymal stromal cells.Immunological and histochemical analyses of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders.Absence of CC chemokine receptors 2a and 2b from human adipose lineage cells.Depolarisation of the plasma membrane in the arsenic trioxide (As2O3)-and anti-CD95-induced apoptosis in myeloid cells.Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigens.Imatinib impairs the proliferation and function of CD4+CD25+ regulatory T cells in a dose-dependent manner.A Subpopulation of Stromal Cells Controls Cancer Cell Homing to the Bone Marrow.The role of mitochondrial targeting in arsenic trioxide-induced apoptosis in myeloid cell lines.International Forum on GMP-grade human platelet lysate for cell propagation.International Forum on GMP-grade human platelet lysate for cell propagation: summary.Comparative Analysis of Different Platelet Lysates and Platelet Rich Preparations to Stimulate Tendon Cell Biology: An In Vitro Study.Leukemic progenitor cells are susceptible to targeting by stimulated cytotoxic T cells against immunogenic leukemia-associated antigens.Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications.S100A4 and uric acid promote mesenchymal stromal cell induction of IL-10+/IDO+ lymphocytes.Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy.Iron-loaded PLLA nanoparticles as highly efficient intracellular markers for visualization of mesenchymal stromal cells by MRI.GMP-Compliant Expansion of Clinical-Grade Human Mesenchymal Stromal/Stem Cells Using a Closed Hollow Fiber Bioreactor.The tumor antigens RHAMM and G250/CAIX are expressed in head and neck squamous cell carcinomas and elicit specific CD8+ T cell responses.Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial.Immunological reconstitution in a patient with ZAP-70 deficiency following transfusion of blood lymphocytes from a previously transplanted sibling without conditioningEwing's sarcoma cells with CD57-associated increase of tumorigenicity and with neural crest-like differentiation capacityCell therapy induced regeneration of severely atrophied mandibular bone in a clinical trialAccelerated telomere shortening in glycosylphosphatidylinositol (GPI)-negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by proaerolysin flow-FISHGMP-Compliant Isolation and Expansion of Bone Marrow-Derived MSCs in the Closed, Automated Device Quantum Cell Expansion System
P50
Q30317424-7C258C1C-C582-4ED5-B025-6152EF5EEF0BQ33256592-FB222BB3-71C1-4107-B04A-99F05CA964EBQ33872679-03B3F1B1-9227-4DB2-87F9-06014F341338Q34891147-F8E1BA8A-1C1B-427B-8A73-F64191BC4170Q35652081-95E728A1-1213-4E37-BD22-121255708F99Q35994852-FA3E43AA-7070-4BCE-90DC-41312C744B8CQ37606443-FD2AF89F-E3AB-49AA-95E1-60F593DB01EAQ37872600-FF4B3098-5DA1-45D8-9959-AA0BF3554DC6Q39831906-313FD509-D8A0-4B38-8A90-C3BEBB35816DQ39870567-239B35FF-8697-4ACC-81C7-4B83D510551EQ40990126-CB40E085-5F02-4C20-96B3-6B269E62B6F6Q41950391-F3EC070E-9070-4AFF-BC52-2AE68386C925Q41963473-6AF393D5-066C-42F1-B41E-C8D4BC84BB2FQ42242005-1C6B2B8A-589F-4123-BF69-0F43942E7251Q42455438-75461B64-0861-4CF7-90C9-9BA534F1F010Q42507583-F1B27909-F2C5-4DD9-B12B-84C0DC3E621BQ42554975-68E769EA-9BB3-4860-AD6D-EF6E074D7AF2Q42692619-9A7EF0F6-5E54-4EED-BEB3-CC96BAF20DC7Q44656990-5E3978D7-06A1-426B-9988-16788061BEDDQ45175166-CCA6A6DF-A3A6-4693-8B04-8042655FEE04Q46488793-28FF9ECD-66CC-4B73-A3BD-B0A6BCA0D846Q46969850-D16710CB-6882-40A1-992A-2D443E2285BDQ47288981-695B1532-F85B-45D7-BB36-8C8FA8811AF9Q47307384-28C05016-B67E-46A6-ABE2-B6003CE00FF1Q47409155-9BF5B6C7-8E3F-4C3B-8797-036332CCF9A9Q47565005-CF4E028B-8778-4BF6-848E-EDFD0BAF5E57Q47740580-8121F3FD-77EA-4BCD-BB53-45214D0C175FQ50447093-2E40AC54-8A38-4D74-B977-955BA127B8CEQ50459927-D6791E70-5B02-4719-9205-CF8B78ABAA6EQ50472278-5FC8CC10-1507-44A7-8CBF-3BDDD6BC02F0Q50475656-A870F341-218B-44FF-86F3-9AE077915511Q50623027-0BE76FE7-7E57-4180-97EF-AB9AC1314271Q51313339-F0715FB9-636D-41D9-A424-6A7FD6B78EF0Q51825145-CD87BBC7-FFFB-4F7C-BFFE-E5075B971724Q52621157-243A6312-C09E-4C98-8A81-C8B3D934CEC2Q57384552-F3636647-6305-4F29-8F7D-C8D93FE3E6AFQ57384557-E3FFECCF-8E18-4E91-BABD-761C7A6DEF5AQ58793452-5CCD7781-F723-4A58-85CA-9000988E3B64Q60028852-35D7FB77-7C99-4974-B65D-3CD0D6391CAAQ60628176-9ECE85A2-5157-4CD9-9073-B0E649443E11
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Markus Rojewski
@ast
Markus Rojewski
@en
Markus Rojewski
@es
Markus Rojewski
@nl
Markus Rojewski
@sl
type
label
Markus Rojewski
@ast
Markus Rojewski
@en
Markus Rojewski
@es
Markus Rojewski
@nl
Markus Rojewski
@sl
prefLabel
Markus Rojewski
@ast
Markus Rojewski
@en
Markus Rojewski
@es
Markus Rojewski
@nl
Markus Rojewski
@sl
P106
P21
P31
P496
0000-0003-4265-0442